Chondroitin sulfate (CS), a natural anionic mucopolysaccharide, belonging to the
glycosaminoglycan family, acts as the primary element of the extracellular matrix (ECM) of …

Modern medicine will unequivocally include regenerative medicine as a major breakthrough
in the re‐establishment of damaged or lost tissues due to degenerative diseases or injury. In …

Researchers have accumulated a decade of experience with autologous cell therapy in the
treatment of critical limb ischemia (CLI). We conducted a systematic review of clinical trials in …

The inadequacy of existing therapeutic tools together with the paucity of organ donors have
always led medical researchers to innovate the current treatment methods or to discover …

The ubiquitous antimicrobial peptides (AMPs), with a broad range of antimicrobial activities,
represent a great promise for combating the multi-drug resistant infections. In this study …

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. The use of stem
cells to improve recovery of the injured heart after myocardial infarction (MI) is an important …

Ischemic heart disease (IHD) is the leading cause of death and disability worldwide. An
early and accurate diagnosis of IHD is necessary to improve outcomes. According to recent …

Background: Cardiovascular diseases (CVD) still represent the leading cause of mortality
worldwide, despite the remarkable advances in interventional cardiology, cardiac surgery …

Stem cells are a population of cells that has infinite or long-term self-renewal ability and can
produce various kinds of descendent cells. Transforming growth factor β (TGF-β) family is a …

The pandemic of cardiovascular disease is continuously expanding as the result of
changing life styles and diets throughout the Old and New World. Immediate intervention …